Purchase Order 75N91020P00545
Award Date 6/19/20
Potential Completion Date 6/18/21
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Denville, NJ 07834, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Diagenode, LLC for $24,284.30 in scientific laboratory equipment, effective March 12, 2021, with completion by April 11, 2021. Performance occurs in Denville, New Jersey. The order is firm fixed price with no small business set-aside.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $25,000 purchase order to Diagenode, LLC for scientific equipment. Under the firm fixed price contract, Diagenode will provide the specified equipment to support the National Cancer Institute's research efforts. The place of performance is Diagenode's facility in Denville, New Jersey. The contract period runs from September 22, 2023 through December 26, 2023. No subcontractors or set...
- The National Institute on Aging issued a purchase order to Diagenode, LLC on January 27, 2020, with a ceiling value of $23,308.50 for firm fixed-price commercial items. Performance is scheduled to conclude by April 6, 2020, and will be executed in Denville, New Jersey, where the awardee is headquartered. The order procures specialized laboratory instrumentation and epigenetics research services, including DNA analysis tools and associated genomic methodologies aligned with the institute's...
- <p>The National Human Genome Research Institute awarded a purchase order to Diagenode, LLC for laboratory equipment and supplies valued at $24,727.60 on February 27, 2019. Performance is located in Denville, New Jersey. The order is firm fixed price with an ultimate completion date of March 26, 2019. No small business set-aside was used.</p>
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $22,130 in lab equipment on June 9, 2021, with completion by July 9, 2021. The award carries no small business set-aside. Performance is in Carlsbad, California. The order is firm fixed price and was issued to de-obligate expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 close of the period of availability.</p>
- The National Cancer Institute awarded a purchase order to Qiagen, LLC for scientific equipment on August 24, 2021, with a ceiling value of $24,930.00 and a firm fixed price. The order was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability. Place of performance is Germantown, Maryland. The ultimate completion date is December 31, 2021....
- <p>The National Cancer Institute awarded a purchase order to Diagenode, LLC for $4,750.00 on August 16, 2017, for parts replacement, calibration, and service repair of a Bioruptor instrument used for DNA and chromatin shearing. Place of performance is Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of September 15, 2017. No small business set-aside was used.</p>
- <p>The National Cancer Institute issued a purchase order to Qiagen, LLC on December 18, 2020, for scientific equipment valued at $24,984.12, with completion required by January 31, 2021. Performance takes place in Germantown, Maryland. The order is priced on a firm fixed price basis.</p>
- The National Cancer Institute (NCI) awarded a $23,969.15 firm-fixed-price purchase order to Diagenode, LLC, a global life sciences company specializing in epigenetics research. The contract is for the delivery of a Bioruptor PLUS sonication device, which is used for DNA shearing in chromatin immunoprecipitation (ChIP) workflows. Diagenode has secured numerous federal contracts from agencies such as the National Institutes of Health (NIH), Environmental Protection Agency (EPA), and U.S....
The National Cancer Institute awarded a purchase order to Diagenode, LLC for scientific equipment with a ceiling value of $22,682.10, effective June 19, 2020. The order, which is firm fixed-price with no small business set-aside, calls for equipment to be delivered to Denville, New Jersey, where the awardee is headquartered. Ultimate completion was scheduled for June 18, 2021.
Generated 7/17/26, 9:46 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.7k | 6/18/20 |